Prior to joining DK Pierce & Associates, Ms. Serluco was Director of Specialty Injectables Market Research for ICORE Healthcare (a Magellan Health Company), with responsibility for leading qualitative and quantitative strategic marketing research activities. "Janet's background with physician-administered, self-injectable and oral drugs and biologics – especially in oncology – is outstanding," said Denise K. Pierce, President of DK Pierce & Associates. "We are excited about the breadth and depth of Janet's expertise and how she will enhance our strength and reputation in strategic reimbursement consulting services."

Ms. Serluco commented, "I am looking forward to working with the entire DK Pierce and Associates team to advance our mission to ensure patient access to appropriate care and facilitate effective communication between all stakeholders in the reimbursement environment."

Ms. Serluco's market research experience began at National Analysts and continued at Rhone-Poulenc Rorer Pharmaceuticals (now Sanofi-Aventis) where she held brand management roles across multiple lines of business. Her expertise expanded with medical marketing and advertising roles, including launch products, at Barton & Pittinos and Core Marketing Associates. She also served in marketing and business development for Welnia, LLC, a start-up wellness and lifestyle medicine company.

Ms. Serluco received a B.A. in psychology with honors from Temple University, an M.S. in Program Evaluation and Applied Social Research from Drexel University, and currently serves as a graduate-level Adjunct Professor of Marketing Research and Marketing Management in the G. H. Walker School of Business and Technology at Webster University in Orlando, FL.

About DK Pierce & Associates, Inc.

DK Pierce & Associates, Inc. is a specialized healthcare and reimbursement consulting firm applying innovative solutions that transcend current business paradigms. The company is a certified Women's Business Enterprise (WBE) with expertise in clinical and economic implications of oncology patient care, physician-administered drugs and biologics, and novel delivery systems provide the company a unique perspective on health care delivery challenges. Learn more about the company's consulting services at www.dkpierce.net